{"id":"serotonin","rwe":[{"pmid":"41912481","year":"2026","title":"Structural basis of human zinc-activated channel (ZAC) signaling and modulation.","finding":"","journal":"Cell discovery","studyType":"Clinical Study"},{"pmid":"41912444","year":"2026","title":"Disrupted Modular Integration of the Reward System Is Associated With Social Deficits in Autism Spectrum Disorder.","finding":"","journal":"Autism research : official journal of the International Society for Autism Research","studyType":"Clinical Study"},{"pmid":"41911448","year":"2026","title":"Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system.","finding":"","journal":"Proceedings of the National Academy of Sciences of the United States of America","studyType":"Clinical Study"},{"pmid":"41910195","year":"2026","title":"Fecal microbiota transplantation and Akkermansia muciniphila restore neurodevelopment and behavior via the gut-brain axis in autism-like zebrafish.","finding":"","journal":"The ISME journal","studyType":"Clinical Study"},{"pmid":"41909693","year":"2026","title":"Glycocalyx strengthens endothelial barrier function and protects from angioedema inducing compounds.","finding":"","journal":"Frontiers in immunology","studyType":"Clinical Study"}],"_fda":{"id":"2715520e-246a-4160-b71b-cc2a81d8e37f","set_id":"090e4a23-3e1b-4b0c-a0cc-0172b05f7b64","openfda":{"nui":["N0000185372","N0000175629","N0000184306","N0000185001","M0008890","M0000728","N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"upc":["0810151884820"],"unii":["V5VD430YW9","XTC0D02P6C","6P669D8HQ8","8EKI9QEE2H","4D7G21HDBC","433OSF3U8A","S003A158SB","00543AP1JV","F1T8QT9U8B","YKH834O4BH","C88X29Y479","RHH784E0K6","GKN429M9VS","6A001Y4M5A","451W47IQ8X","7FT6QUT299","1NM3M2487K","C151H8M554","4GB5DQR532","N6R0856Z79","1NT28V9397"],"route":["ORAL"],"spl_id":["2715520e-246a-4160-b71b-cc2a81d8e37f"],"brand_name":["Shame"],"spl_set_id":["090e4a23-3e1b-4b0c-a0cc-0172b05f7b64"],"package_ndc":["43742-2276-1"],"product_ndc":["43742-2276"],"generic_name":["ADRENALINUM, AGNUS CASTUS, ALOE, AMBRA GRISEA, AURUM MURIATICUM NATRONATUM, BARYTA CARBONICA, CALCAREA IODATA, CANDIDA ALBICANS, CEREBRUM SUIS, CINCHONA OFFICINALIS, DIGITALIS PURPUREA, HYPOTHALAMUS SUIS, IGNATIA AMARA, LAC DEFLORATUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, RHUS GLABRA, SACCHARUM OFFICINALE, SEROTONIN (HYDROCHLORIDE), STAPHYSAGRIA, THUJA OCCIDENTALIS"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Fungal Proteins [CS]","Allergens [CS]","Catecholamines [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]","Increased IgG Production [PE]"],"substance_name":["ALOE","AMBERGRIS","BARIUM CARBONATE","CALCIUM IODIDE","CANDIDA ALBICANS","CHASTE TREE FRUIT","CINCHONA OFFICINALIS BARK","DELPHINIUM STAPHISAGRIA SEED","DIGITALIS","EPINEPHRINE","LYCOPODIUM CLAVATUM SPORE","RHUS GLABRA TOP","SEROTONIN HYDROCHLORIDE","SKIM MILK","SODIUM CHLORIDE","SODIUM TETRACHLOROAURATE","STRYCHNOS IGNATII SEED","SUCROSE","SUS SCROFA CEREBRUM","SUS SCROFA HYPOTHALAMUS","THUJA OCCIDENTALIS LEAFY TWIG"],"pharm_class_epc":["Non-Standardized Fungal Allergenic Extract [EPC]","alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"manufacturer_name":["Deseret Biologicals, Inc."],"is_original_packager":[true]},"purpose":["PURPOSE: Adrenalinum – Self-Consciousness, Agnus Castus - Shame, Aloe - Embarrassment, Ambra Grisea - Embarrassment, Aurum Muriaticum Natronatum – Lack of Confidence, Baryta Carbonica - Worthlessness, Calcarea Iodata – Fear of Failure, Candida Albicans - Guilt, Cerebrum Suis – Avoiding Attention, Cinchona Officinalis – Excessive Apologizing, Digitalis Purpurea - Shame, Hypothalamus Suis – Lack of Confidence, Ignatia Amara – Fear of Strangers, Lac Defloratum - Hiding, Lycopodium Clavatum – Fear of Failure, Natrum Muriaticum – Avoiding Attention, Rhus Glabra – Poor Eye Contact, Saccharum Officinale - Worthlessness, Serotonin (Hydrochloride) - Guilt, Staphysagria - Embarrassment, Thuja Occidentalis - Embarrassment"],"version":"1","warnings":["WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing."],"questions":["QUESTIONS: Dist. By: Deseret Biologicals, Inc. 469 W. Parkland Drive Sandy, UT 84070 www.desbio.co 800-827-8204"],"effective_time":"20250507","active_ingredient":["ACTIVE INGREDIENTS: Adrenalinum 6X, 12X, 30X, Agnus Castus 12X, Aloe 8X, Ambra Grisea 6X, 12X, 30X, Aurum Muriaticum Natronatum 12X, Baryta Carbonica 12X, Calcarea Iodata 12X, Candida Albicans 12X, 18X, 30X, Cerebrum Suis 8X, Cinchona Officinalis 12X, Digitalis Purpurea 12X, Hypothalamus Suis 8X, Ignatia Amara 12X, Lac Defloratum 6X, 12X, 30X, Lycopodium Clavatum 12X, Natrum Muriaticum 6X, Rhus Glabra 12X, Saccharum Officinale 30X, Serotonin (Hydrochloride) 6X, 12X, 30X, Staphysagria 12X, Thuja Occidentalis 6X, 12X, 30X."],"inactive_ingredient":["INACTIVE INGREDIENTS: Demineralized water, 25% ethanol"],"indications_and_usage":["USES: • For the temporary relief of symptoms including: • self-consciousness • shame • embarrassment • fear of strangers • lack of confidence • worthlessness •guilt • avoiding attention • hiding • excessive apologizing • fear of failure • poor eye contact These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration."],"dosage_and_administration":["DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Shame Adrenalinum, Agnus Castus, Aloe, Ambra Grisea, Aurum Muriaticum Natronatum, Baryta Carbonica, Calcarea Iodata, Candida Albicans, Cerebrum Suis, Cinchona Officinalis, Digitalis Purpurea, Hypothalamus Suis, Ignatia Amara, Lac Defloratum, Lycopodium Clavatum, Natrum Muriaticum, Rhus Glabra, Saccharum Officinale, Serotonin (Hydrochloride), Staphysagria, Thuja Occidentalis EPINEPHRINE EPINEPHRINE CHASTE TREE FRUIT CHASTE TREE ALOE ALOE AMBERGRIS AMBERGRIS SODIUM TETRACHLOROAURATE TETRACHLOROAURATE ION BARIUM CARBONATE BARIUM CATION CALCIUM IODIDE CALCIUM CATION CANDIDA ALBICANS CANDIDA ALBICANS SUS SCROFA CEREBRUM SUS SCROFA CEREBRUM CINCHONA OFFICINALIS BARK CINCHONA OFFICINALIS BARK DIGITALIS DIGITALIS SUS SCROFA HYPOTHALAMUS SUS SCROFA HYPOTHALAMUS STRYCHNOS IGNATII SEED STRYCHNOS IGNATII SEED SKIM MILK SKIM MILK LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE SODIUM CHLORIDE CHLORIDE ION RHUS GLABRA TOP RHUS GLABRA TOP SUCROSE SUCROSE SEROTONIN HYDROCHLORIDE SEROTONIN DELPHINIUM STAPHISAGRIA SEED DELPHINIUM STAPHISAGRIA SEED THUJA OCCIDENTALIS LEAFY TWIG THUJA OCCIDENTALIS LEAFY TWIG WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: In case of overdose, contact a physician or Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: Shame Homeopathic NDC 43742-2276-1 1 FL OZ (30 ml) Shame"]},"tags":[{"label":"Non-Standardized Fungal Allergenic Extract [EPC]","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"self-consciousness","category":"indication"},{"label":"shame","category":"indication"},{"label":"embarrassment","category":"indication"},{"label":"fear of strangers","category":"indication"},{"label":"lack of confidence","category":"indication"},{"label":"worthlessness","category":"indication"},{"label":"Deseret Biologicals, Inc.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INTERACTION","source":"FDA FAERS","actionTaken":"90 reports"},{"date":"","signal":"SUICIDE ATTEMPT","source":"FDA FAERS","actionTaken":"86 reports"},{"date":"","signal":"ACUTE KIDNEY INJURY","source":"FDA FAERS","actionTaken":"84 reports"},{"date":"","signal":"INTENTIONAL OVERDOSE","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"MAJOR DEPRESSION","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"METABOLIC ACIDOSIS","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"PHYSICAL DECONDITIONING","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"SEROTONIN SYNDROME","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"DRUG EXPOSURE DURING PREGNANCY","source":"FDA FAERS","actionTaken":"46 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"31 reports"}]},"trials":[],"aliases":[],"company":"Deseret Biologicals, Inc.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SEROTONIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:14:43.948811+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Serotonin","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:14:51.719507+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:14:50.324552+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SEROTONIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:14:50.527176+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:14:42.660792+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:14:42.660823+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:14:42.660829+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:14:52.266303+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL535832/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:14:51.370783+00:00"}},"allNames":"shame","offLabel":[],"synonyms":["Shame","ALOE"],"timeline":[],"approvals":[],"brandName":"Shame","ecosystem":[],"mechanism":{"moaClass":"Adrenergic alpha-Agonists [MoA]","modality":"Small Molecule","drugClass":"Non-Standardized Fungal Allergenic Extract [EPC]","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action of Shame is unknown, but it may involve the modulation of the hypothalamic-pituitary-adrenal (HPA) axis, the serotonin system, or other neuroendocrine pathways."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Shame","title":"Shame","extract":"Shame is an unpleasant self-conscious and moral emotion often associated with negative self-evaluation; motivation to quit; and feelings of pain, exposure, distrust, powerlessness, and worthlessness."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"SEROTONIN\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=serotonin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=serotonin","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Shame","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-31T10:37:42.880887","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:14:53.696237+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"serotonin","indications":{"approved":[{"name":"self-consciousness","source":"OpenFDA Label","regulator":"FDA"},{"name":"shame","source":"OpenFDA Label","regulator":"FDA"},{"name":"embarrassment","source":"OpenFDA Label","regulator":"FDA"},{"name":"fear of strangers","source":"OpenFDA Label","regulator":"FDA"},{"name":"lack of confidence","source":"OpenFDA Label","regulator":"FDA"},{"name":"worthlessness","source":"OpenFDA Label","regulator":"FDA"},{"name":"guilt","source":"OpenFDA Label","regulator":"FDA"},{"name":"avoiding attention","source":"OpenFDA Label","regulator":"FDA"},{"name":"hiding","source":"OpenFDA Label","regulator":"FDA"},{"name":"excessive apologizing","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07227597","phase":"PHASE1,PHASE2","title":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-29","conditions":["Small Cell Lung Cancer Extensive Stage"],"enrollment":170,"completionDate":"2030-12-30"},{"nctId":"NCT00004847","phase":"PHASE1","title":"Diagnosis of Pheochromocytoma","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2000-03-22","conditions":["Pheochromocytoma","Endocrine Disease","Endocrine Diseases"],"enrollment":3000,"completionDate":"2048-11-30"},{"nctId":"NCT07361796","phase":"NA","title":"The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":["Herpes Zoster","Pain","Postherpetic Neuralgia"],"enrollment":832,"completionDate":"2027-12-31"},{"nctId":"NCT06925737","phase":"PHASE3","title":"A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":["Prostate Cancer","Prostatic Neoplasms"],"enrollment":1440,"completionDate":"2031-01-06"},{"nctId":"NCT05241041","phase":"NA","title":"Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms","status":"COMPLETED","sponsor":"Inha University Hospital","startDate":"2021-09-13","conditions":["Gambling"],"enrollment":198,"completionDate":"2025-09-28"},{"nctId":"NCT06843447","phase":"PHASE1,PHASE2","title":"A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-15","conditions":["Ovarian Cancer Recurrent"],"enrollment":280,"completionDate":"2029-03-27"},{"nctId":"NCT06532604","phase":"NA","title":"Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Centre Psychothérapique de Nancy","startDate":"2026-09-01","conditions":["Major Depressive Disorder"],"enrollment":108,"completionDate":"2028-03-01"},{"nctId":"NCT07390981","phase":"NA","title":"Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2026-03-01","conditions":["Major Depressive Disorder"],"enrollment":114,"completionDate":"2028-12-31"},{"nctId":"NCT07490353","phase":"PHASE1","title":"Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2025-11-01","conditions":["Depression - Major Depressive Disorder","Anhedonia"],"enrollment":85,"completionDate":"2028-05-31"},{"nctId":"NCT06780085","phase":"PHASE2","title":"A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":["Carcinoma, Non-Small-Cell Lung"],"enrollment":96,"completionDate":"2032-03-12"},{"nctId":"NCT00646022","phase":"","title":"Natural History of Familial Carcinoid Tumor","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2008-08-25","conditions":["Carcinoid"],"enrollment":1600,"completionDate":""},{"nctId":"NCT06780098","phase":"PHASE2","title":"Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-28","conditions":["Lung Neoplasm"],"enrollment":144,"completionDate":"2032-03-02"},{"nctId":"NCT06159673","phase":"PHASE2,PHASE3","title":"ACP-204 in Adults With Alzheimer's Disease Psychosis","status":"RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2023-11-14","conditions":["Alzheimer's Disease Psychosis"],"enrollment":1074,"completionDate":"2028-02"},{"nctId":"NCT04497168","phase":"PHASE2","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-04-01","conditions":["Parkinson Disease"],"enrollment":58,"completionDate":"2026-03-02"},{"nctId":"NCT04123314","phase":"EARLY_PHASE1","title":"Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-03-24","conditions":["Depressive Symptoms","Depression","Alzheimer Disease","Mild Cognitive Impairment"],"enrollment":20,"completionDate":"2026-12-31"},{"nctId":"NCT03947216","phase":"PHASE2","title":"Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-23","conditions":["Parkinson Disease"],"enrollment":117,"completionDate":"2024-06-17"},{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":["Sleep Disordered Breathing","Able Bodied"],"enrollment":200,"completionDate":"2026-12-31"},{"nctId":"NCT06559306","phase":"PHASE3","title":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-07-25","conditions":["Depressive Disorder, Major"],"enrollment":752,"completionDate":"2026-12-30"},{"nctId":"NCT06809595","phase":"PHASE3","title":"A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)","status":"RECRUITING","sponsor":"Definium Therapeutics US, Inc.","startDate":"2025-01-29","conditions":["Generalized Anxiety Disorder"],"enrollment":250,"completionDate":"2027-05"},{"nctId":"NCT06941844","phase":"PHASE3","title":"A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Definium Therapeutics US, Inc.","startDate":"2025-04-14","conditions":["Major Depressive Disorder"],"enrollment":149,"completionDate":"2027-05"},{"nctId":"NCT05851898","phase":"PHASE4","title":"Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-04-08","conditions":["Depression in Old Age","Fragility Fracture"],"enrollment":100,"completionDate":"2028-12"},{"nctId":"NCT05841030","phase":"","title":"A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-28","conditions":["Depressive Disorder, Major"],"enrollment":545,"completionDate":"2026-03-13"},{"nctId":"NCT07452341","phase":"NA","title":"Effect of Virtual Reality on Depression in Adolescent Females","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-08-01","conditions":["Depression"],"enrollment":48,"completionDate":"2027-02-01"},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":["Sleep Quality","Sleep Disorders","Insomnia"],"enrollment":100,"completionDate":"2025-12-04"},{"nctId":"NCT07458022","phase":"PHASE2","title":"MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Child Health Sciences and Children's Hospital, Lahore","startDate":"2025-12-01","conditions":["Major Depressive Diorder"],"enrollment":50,"completionDate":"2026-04"},{"nctId":"NCT07455838","phase":"NA","title":"Impact of Virtual Reality Pelvic Floor Training on Postpartum Stress Urinary Incontinence","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-10","conditions":["Stress Urinary Incontinence"],"enrollment":50,"completionDate":"2026-05-31"},{"nctId":"NCT07326163","phase":"NA","title":"The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Bilecik Seyh Edebali Universitesi","startDate":"2026-03-01","conditions":["Fibromyalgia","Aromatherapy","Cost"],"enrollment":175,"completionDate":"2027-01-01"},{"nctId":"NCT07444788","phase":"PHASE1","title":"Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-03-31","conditions":["5-methoxy-dimethyltryptamine (5-MeO-DMT)"],"enrollment":40,"completionDate":"2028-03-01"},{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":["Major Depressive Disorder (MDD)"],"enrollment":30,"completionDate":"2028-08"},{"nctId":"NCT07443150","phase":"NA","title":"The Effect of BWSTT on Neuroendocrine Profile and Functional Recovery in Stroke Patients","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2017-07-03","conditions":["Stroke, Ischemic","Subacute Stroke"],"enrollment":40,"completionDate":"2024-05-24"},{"nctId":"NCT05407064","phase":"PHASE2","title":"A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms","status":"COMPLETED","sponsor":"Definium Therapeutics US, Inc.","startDate":"2022-08-24","conditions":["Anxiety Generalized"],"enrollment":198,"completionDate":"2023-11-27"},{"nctId":"NCT07329621","phase":"PHASE1","title":"A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults","status":"RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-01-15","conditions":["Incomplete Response - Major Depressive Disorder (IR-MDD)"],"enrollment":18,"completionDate":"2027-02-11"},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":["Liver Cirrhosis With Diabetes"],"enrollment":64,"completionDate":"2025-10-01"},{"nctId":"NCT07440069","phase":"PHASE4","title":"Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":["Labor Pain"],"enrollment":300,"completionDate":"2026-09-30"},{"nctId":"NCT06741228","phase":"PHASE3","title":"A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)","status":"RECRUITING","sponsor":"Definium Therapeutics US, Inc.","startDate":"2024-12-11","conditions":["Generalized Anxiety Disorder"],"enrollment":200,"completionDate":"2026-11"},{"nctId":"NCT07013331","phase":"NA","title":"A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-04-01","conditions":["Epilepsy","Dravet Syndrome","Drug Resistant Epilepsy","Healthy Controls"],"enrollment":30,"completionDate":"2028-12-01"},{"nctId":"NCT05999240","phase":"PHASE2","title":"Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder","status":"RECRUITING","sponsor":"New York State Psychiatric Institute","startDate":"2025-10-01","conditions":["Autism Spectrum Disorder"],"enrollment":30,"completionDate":"2026-12-31"},{"nctId":"NCT06987786","phase":"NA","title":"Differences in Mechanistic Measures (Oxytocin and Cortisol) of Therapeutic Alliance Between A Talk-Based Therapy and Soft-Tissue Mobilization in Individuals With Chronic Spinal Pain","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-06-01","conditions":["Spine","Low Back Pain","Neck Pain"],"enrollment":25,"completionDate":"2026-11-30"},{"nctId":"NCT07359482","phase":"PHASE3","title":"sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2026-03-01","conditions":["Post-COVID","POST-Covid 19","Post-COVID Conditions"],"enrollment":160,"completionDate":"2028-05-01"},{"nctId":"NCT06049797","phase":"","title":"A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2023-11-15","conditions":["Hot Flashes"],"enrollment":999,"completionDate":"2026-05-31"},{"nctId":"NCT05550532","phase":"PHASE3","title":"A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-12-06","conditions":["Depressive Disorder, Major","Anhedonia"],"enrollment":444,"completionDate":"2024-11-13"},{"nctId":"NCT07404813","phase":"NA","title":"The Effect of Family Member Voices on Dopamine, Serotonin Levels, and Pain in Patients in Intensive Care Units","status":"ENROLLING_BY_INVITATION","sponsor":"Zeliha CENGİZ","startDate":"2025-02-20","conditions":["Patient Engagement","Intensive Care (ICU)","Family Members' Voices"],"enrollment":78,"completionDate":"2026-02-20"},{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":["Posttraumatic Stress Disorder","Major Depressive Disorder"],"enrollment":26,"completionDate":"2025-03-31"},{"nctId":"NCT07399795","phase":"","title":"Citalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":["Chronic Kidney Disease (CKD)","Elderly","Outpatient"],"enrollment":7110,"completionDate":"2026-01"},{"nctId":"NCT07303907","phase":"PHASE2","title":"A Phase 2A Trial of MM402 for Autism Spectrum Disorder","status":"RECRUITING","sponsor":"Definium Therapeutics US, Inc.","startDate":"2025-12-03","conditions":["Autism Spectrum Disorder","ASD"],"enrollment":20,"completionDate":"2027-08"},{"nctId":"NCT05155280","phase":"NA","title":"Serotonin Role on Brain Circuits Involved in Food Avoidance in Anorexia Nervosa","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2021-12-10","conditions":["Anorexia Nervosa"],"enrollment":57,"completionDate":"2025-07-08"},{"nctId":"NCT07387120","phase":"","title":"Sertraline and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01","conditions":["Chronic Kidney Disease (CKD)","Elderly","Outpatient"],"enrollment":6893,"completionDate":"2026-01"},{"nctId":"NCT06805851","phase":"","title":"Impact of Depression on Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":["Depression","Selective Serotonin Reuptake Inhibitor"],"enrollment":64,"completionDate":"2027-01-30"},{"nctId":"NCT05676827","phase":"","title":"Pain, Central Sensitization and Psychoemotional State in Patients With Chronic Masticatory Muscle Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Wroclaw Medical University","startDate":"2023-09-01","conditions":["TMD","Masticatory Muscle Pain"],"enrollment":102,"completionDate":"2026-12"},{"nctId":"NCT07274241","phase":"","title":"Escitalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":["Chronic Kidney Disease (CKD)","Elderly","Outpatient"],"enrollment":12145,"completionDate":"2025-11-15"},{"nctId":"NCT04216329","phase":"PHASE1","title":"Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-07","conditions":["Gliosarcoma","Newly Diagnosed","Glioblastoma"],"enrollment":11,"completionDate":"2028-07-30"},{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":["Obsessive-Compulsive Disorder"],"enrollment":46,"completionDate":"2024-03-31"},{"nctId":"NCT06633016","phase":"PHASE2","title":"Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)","status":"RECRUITING","sponsor":"Autobahn Therapeutics, Inc.","startDate":"2024-09-20","conditions":["Major Depressive Disorder"],"enrollment":230,"completionDate":"2026-06"},{"nctId":"NCT07318181","phase":"NA","title":"Building Ukraine's Strength in PTSD Treatment and Research","status":"RECRUITING","sponsor":"University of Luxembourg","startDate":"2026-01-01","conditions":["Post Traumatic Stress Disorder","Post Traumatic Stress Disorder PTSD","Post-Traumatic Stress Disorder, PTSD"],"enrollment":120,"completionDate":"2028-05"},{"nctId":"NCT07334223","phase":"NA","title":"Comparison of Intravenous Ondansetron and Low Dose Ketamine in Preventing Post Spinal Shivering","status":"COMPLETED","sponsor":"Mayo Hospital Lahore","startDate":"2020-01-01","conditions":["Postoperative Shivering","Postspinal Shivering"],"enrollment":180,"completionDate":"2020-06-30"},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":["Healthy","Major Depressive Disorder (MDD)"],"enrollment":204,"completionDate":"2027-02-01"},{"nctId":"NCT05756608","phase":"","title":"Fibrosis in Chronic and Delayed Myocardial Infarction","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2022-11-10","conditions":["Aortic Stenosis","Chemotherapy Induced Systolic Dysfunction","Carcinoid Syndrome"],"enrollment":180,"completionDate":"2028-08-31"},{"nctId":"NCT04961190","phase":"PHASE4","title":"A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-05-25","conditions":["Posttraumatic Stress Disorder"],"enrollment":302,"completionDate":"2026-07-15"},{"nctId":"NCT06910774","phase":"","title":"Analysis of Peripheral Serotonin Levels in a Control Cohort","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2025-06-23","conditions":["No Condition : to Establish Reference Serum Serotonin Levels in a Control Cohort"],"enrollment":100,"completionDate":"2025-11-16"},{"nctId":"NCT07302087","phase":"","title":"Platelet Serotonin Deficiencies: the Strasbourg Experience","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-11-25","conditions":["Hemorrhagic Syndrome"],"enrollment":50,"completionDate":"2026-02"},{"nctId":"NCT05746845","phase":"","title":"Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis","status":"COMPLETED","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2023-03-06","conditions":["Healthy","Multiple Sclerosis"],"enrollment":100,"completionDate":"2024-07-01"},{"nctId":"NCT02038608","phase":"NA","title":"Compensatory Mechanisms in Parkinson Disease (PD)","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":["Parkinson's Disease"],"enrollment":49,"completionDate":"2015-07"},{"nctId":"NCT03910387","phase":"PHASE2","title":"Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-04-17","conditions":["Locally Advanced Unresectable Pancreatic Adenocarcinoma","Metastatic Pancreatic Adenocarcinoma","Recurrent Pancreatic Adenocarcinoma","Stage III Pancreatic Cancer AJCC v8","Stage IV Pancreatic Cancer AJCC v8"],"enrollment":23,"completionDate":"2022-06-29"},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":["Bipolar I Disorder","Depression"],"enrollment":2726,"completionDate":"2030-02-28"},{"nctId":"NCT02783430","phase":"PHASE2,PHASE3","title":"Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-09-08","conditions":["Depression"],"enrollment":42,"completionDate":"2024-03-08"},{"nctId":"NCT06952920","phase":"PHASE3","title":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2025-08-21","conditions":["Standard Quadruple Antiemetic Therapy","Electroacupuncture","Chemotherapy-induced Gastrointestinal Symptom Cluster"],"enrollment":388,"completionDate":"2028-06-30"},{"nctId":"NCT06665516","phase":"","title":"Frequency and Impact of Iron Deficiency in Pain Clinic Patients","status":"COMPLETED","sponsor":"McMaster University","startDate":"2025-03-19","conditions":["Iron Deficiency","Fibromyalgia"],"enrollment":81,"completionDate":"2025-06-09"},{"nctId":"NCT06295562","phase":"PHASE4","title":"Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2024-11-05","conditions":["Obstructive Sleep Apnea of Adult"],"enrollment":45,"completionDate":"2025-10-22"},{"nctId":"NCT03466346","phase":"NA","title":"SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-08-31","conditions":["Depression, Unipolar","Posttraumatic Stress Disorder","Trauma"],"enrollment":2162,"completionDate":"2024-05-06"},{"nctId":"NCT06474286","phase":"NA","title":"Prucalopride for Cognitive Functioning in Schizophrenia","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-07-31","conditions":["Schizophrenia"],"enrollment":34,"completionDate":"2026-12-31"},{"nctId":"NCT07239011","phase":"PHASE1,PHASE2","title":"Dapagliflozin in Depression","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-01","conditions":["Depression"],"enrollment":60,"completionDate":"2026-12-20"},{"nctId":"NCT06081179","phase":"PHASE1","title":"Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2023-10-24","conditions":["Healthy"],"enrollment":122,"completionDate":"2025-09-22"},{"nctId":"NCT05964647","phase":"PHASE1","title":"Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-02-01","conditions":["Healthy"],"enrollment":20,"completionDate":"2025-06-30"},{"nctId":"NCT05455684","phase":"PHASE3","title":"A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-06-22","conditions":["Depressive Disorder, Major","Anhedonia"],"enrollment":513,"completionDate":"2024-09-18"},{"nctId":"NCT05944926","phase":"PHASE3","title":"Improving Outcomes in Depression in Primary Care in a Low Resource Setting","status":"RECRUITING","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2024-03-18","conditions":["Depression","Depressive Disorder"],"enrollment":1500,"completionDate":"2027-03-31"},{"nctId":"NCT02773082","phase":"NA","title":"DBS for Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Northwell Health","startDate":"2024-07-06","conditions":["Obsessive-Compulsive Disorder (OCD)"],"enrollment":50,"completionDate":"2030-01-01"},{"nctId":"NCT05516732","phase":"","title":"Serotonin Release in Premotor and Motor PD","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2022-07-01","conditions":["Parkinson Disease","Parkinson's","Parkinson's Disease","Neurodegenerative Diseases","Neurodegeneration","Positron Emission Tomography"],"enrollment":42,"completionDate":"2026-06-30"},{"nctId":"NCT04111627","phase":"PHASE2","title":"Exercise Plus Duloxetine for Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2021-10-07","conditions":["Knee Osteoarthritis","Depression"],"enrollment":43,"completionDate":"2025-08-11"},{"nctId":"NCT05518617","phase":"","title":"Molecular and Functional Imaging in Monogenic PD.","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2022-07-01","conditions":["Parkinson Disease","Nervous System Disorder","Neurodegenerative Diseases","Neurodegenerative Disease, Hereditary","Parkinson's"],"enrollment":45,"completionDate":"2026-06-30"},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":["Type 1 Diabetes Mellitus"],"enrollment":60,"completionDate":"2026-12-15"},{"nctId":"NCT03513185","phase":"","title":"Assessment of SSD in Outpatients Using SSS-CN","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2017-09-01","conditions":["Somatization Disorder"],"enrollment":1863,"completionDate":"2021-12-30"},{"nctId":"NCT07192367","phase":"PHASE4","title":"Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Emine Kanmaz","startDate":"2024-11-15","conditions":["Social Anxiety Disorder"],"enrollment":56,"completionDate":"2026-12"},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":["Major Depressive Disorder"],"enrollment":228,"completionDate":"2025-08-22"},{"nctId":"NCT07189299","phase":"NA","title":"Microdosing LSD in Women With Premenstrual Disorders","status":"NOT_YET_RECRUITING","sponsor":"Friederike Holze","startDate":"2025-10-01","conditions":["PMS","PMDD"],"enrollment":150,"completionDate":"2030-01-01"},{"nctId":"NCT04829318","phase":"PHASE4","title":"A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.","startDate":"2021-04-26","conditions":["Depressive Disorder, Major"],"enrollment":183,"completionDate":"2024-07-22"},{"nctId":"NCT07171814","phase":"","title":"Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework","status":"NOT_YET_RECRUITING","sponsor":"Lianxin Wang","startDate":"2025-09-30","conditions":["Premenstrual Syndrome"],"enrollment":266,"completionDate":"2027-09-30"},{"nctId":"NCT03347331","phase":"EARLY_PHASE1","title":"[18F]-F13640 as a New Brain Radiopharmaceutical","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-04-23","conditions":["Neurological Pathology","Healthy Subjects"],"enrollment":20,"completionDate":"2021-12-02"},{"nctId":"NCT06138509","phase":"","title":"Peripheral Serotonin and Albinism","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-02-06","conditions":["Oculocutaneous Albinism"],"enrollment":160,"completionDate":"2026-02"},{"nctId":"NCT06443242","phase":"NA","title":"Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Mohammad Farris Iman Leong Bin Abdullah","startDate":"2025-12-01","conditions":["Major Depressive Disorder","Insomnia"],"enrollment":120,"completionDate":"2027-08-31"},{"nctId":"NCT06677229","phase":"PHASE1,PHASE2","title":"Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury","status":"RECRUITING","sponsor":"Technophage, SA","startDate":"2025-08-01","conditions":["Acute Spinal Cord Injury (SCI)"],"enrollment":28,"completionDate":"2027-06"},{"nctId":"NCT07161492","phase":"NA","title":"A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2025-09","conditions":["Depressive Disorder, Major","Cognitive Impairment"],"enrollment":182,"completionDate":"2028-10"},{"nctId":"NCT06763081","phase":"","title":"Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2025-03-01","conditions":["Behavioral Activation","Major Depressive Disorder","Anxiety Disorders","Antidepressant Drug Adverse Reaction","Obsessive Compulsive Disorder (OCD)","Major Depression"],"enrollment":160,"completionDate":"2030-12-31"},{"nctId":"NCT05290285","phase":"NA","title":"Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo","status":"RECRUITING","sponsor":"Villa Garda Hospital","startDate":"2022-07-01","conditions":["Anorexia Nervosa"],"enrollment":92,"completionDate":"2027-01-01"},{"nctId":"NCT07153406","phase":"PHASE3","title":"Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2025-09-15","conditions":["Depressive Disorder"],"enrollment":220,"completionDate":"2029-01-15"},{"nctId":"NCT06746441","phase":"PHASE2","title":"Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-01","conditions":["Major Depressive Disorder"],"enrollment":60,"completionDate":"2025-07-30"},{"nctId":"NCT07144943","phase":"","title":"\"Evolution of Sexual Symptoms in Paraphilic Sexual Offenders With/Without Antiandrogen or SSRI Treatment\"","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-09-15","conditions":["Sexual Disorder, Physiological"],"enrollment":200,"completionDate":"2030-09"},{"nctId":"NCT04373317","phase":"PHASE4","title":"Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-10-24","conditions":["Parkinson's Disease Psychosis"],"enrollment":358,"completionDate":"2027-08-24"},{"nctId":"NCT05138068","phase":"PHASE2","title":"Social Anxiety MDMA-Assisted Therapy Investigation","status":"COMPLETED","sponsor":"Jason B Luoma","startDate":"2022-04-13","conditions":["Social Anxiety Disorder"],"enrollment":90,"completionDate":"2025-08-12"},{"nctId":"NCT04520178","phase":"PHASE2,PHASE3","title":"Effects of 5HTP on the Injured Human Spinal Cord","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2020-07-01","conditions":["Spinal Cord Injuries"],"enrollment":30,"completionDate":"2026-12-30"},{"nctId":"NCT05524519","phase":"NA","title":"Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder","status":"COMPLETED","sponsor":"The Third Affiliated hospital of Zhejiang Chinese Medical University","startDate":"2022-11-01","conditions":["Major Depressive Disorder"],"enrollment":160,"completionDate":"2023-12-31"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"V5VD430YW9","SPL_ID":"2715520e-246a-4160-b71b-cc2a81d8e37f","chemblId":"CHEMBL535832"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Deseret Biologicals, Inc.","relationship":"Original Developer"}],"publicationCount":110063,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"originalDeveloper":"Deseret Biologicals, Inc.","recentPublications":[{"date":"2026 Mar 31","pmid":"41912481","title":"Structural basis of human zinc-activated channel (ZAC) signaling and modulation.","journal":"Cell discovery"},{"date":"2026 Mar 30","pmid":"41912444","title":"Disrupted Modular Integration of the Reward System Is Associated With Social Deficits in Autism Spectrum Disorder.","journal":"Autism research : official journal of the International Society for Autism Research"},{"date":"2026 Apr 7","pmid":"41911448","title":"Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system.","journal":"Proceedings of the National Academy of Sciences of the United States of America"},{"date":"2026 Mar 30","pmid":"41910195","title":"Fecal microbiota transplantation and Akkermansia muciniphila restore neurodevelopment and behavior via the gut-brain axis in autism-like zebrafish.","journal":"The ISME journal"},{"date":"2026","pmid":"41909693","title":"Glycocalyx strengthens endothelial barrier function and protects from angioedema inducing compounds.","journal":"Frontiers in immunology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Deseret Biologicals, Inc.","companyId":"deseret-biologicals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:14:53.696237+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}